| dc.contributor.author | Ngugi, P M | |
| dc.date.accessioned | 2019-09-04T13:10:35Z | |
| dc.date.available | 2019-09-04T13:10:35Z | |
| dc.date.issued | 2007-09 | |
| dc.identifier | http://www.ncbi.nlm.nih.gov/pubmed/18154201 | |
| dc.identifier | http://hdl.handle.net/11295/17844 | |
| dc.identifier.citation | East Africa Medical Journal. 2007sep;84(9 suppl):S36-9 | en |
| dc.identifier.uri | https://library.adhl.africa/handle/123456789/7428 | |
| dc.description.abstract | OBJECTIVE:
To obtain an update of the treatment of advanced prostate cancer.
DATA SOURCE:
Review of all published literature on advanced prostate cancer was carried out through medline and index medicus search.
DATA SELECTION:
Published data on advanced prostate cancer from June 2005 to June 2007 was included in the review.
DATA EXTRACTION:
Abstracts of articles identified were assessed, read and analysed to determine relevance to the title under review.
DATA SYNTHESIS:
After establishing relevance from the abstract, the entire paper was read, and significant points included in the review.
CONCLUSION:
The mainstay of treatment of advanced prostate cancer remains hormone withdrawal. The introduction of docetaxel based chemotherapy has caused a paradigm shift. | en |
| dc.language.iso | en | en |
| dc.subject | Treatment | en |
| dc.subject | Advanced Prostrate cancer | en |
| dc.title | An update on the treatment of advanced prostate cancer | en |
| dc.type | Article | en |
